tiprankstipranks
Trending News
More News >
Manabi-aid Co.,Ltd. (JP:184A)
:184A
Japanese Market

Manabi-aid Co.,Ltd. (184A) AI Stock Analysis

Compare
0 Followers

Top Page

JP:184A

Manabi-aid Co.,Ltd.

(184A)

Select Model
Select Model
Select Model
Neutral 41 (OpenAI - 5.2)
,
Neutral 41 (OpenAI - 5.2)
,
Neutral 41 (OpenAI - 5.2)
,
Neutral 41 (OpenAI - 5.2)
,
Neutral 41 (OpenAI - 5.2)
,
Neutral 41 (OpenAI - 5.2)
Rating:41Neutral
Price Target:
¥358.00
▼(-35.73% Downside)
Action:ReiteratedDate:03/19/26
The score is driven primarily by weak financial performance, including steep revenue decline, losses, and negative operating/free cash flow. Technicals remain pressured with the stock below major moving averages despite some near-term momentum strength. Valuation is also constrained by a negative P/E tied to unprofitable earnings.
Positive Factors
Manageable leverage
A low debt-to-equity ratio of 0.28 provides structural financial flexibility, reducing near-term solvency pressure and interest burden. That buffer helps the company weather revenue weakness, preserves borrowing capacity for restructuring or investment, and supports longer-term viability.
Stable equity ratio
A relatively stable equity ratio indicates the company retains a base of shareholder capital to absorb losses and sustain operations. This structural balance between assets and equity lessens immediate insolvency risk and supports creditor confidence during multi-quarter turnarounds.
Lower market volatility
A beta near 0.5 implies lower sensitivity to market swings, which can aid management in executing medium-term strategic adjustments without severe financing cost swings. Lower systematic volatility also helps attract conservative capital and reduces refinancing pressure during recovery.
Negative Factors
Steep revenue decline
A >50% revenue decline is a structural concern: it materially reduces scale, undermines operating leverage, and constrains pricing power. Restoring topline takes multiple quarters and is essential to rebuild margins, cash generation, and investor confidence over the 2–6 month horizon and beyond.
Negative operating and free cash flow
Persistently negative operating and free cash flows indicate the business cannot self-fund operations or investment. This forces reliance on external financing or asset dispositions, raises liquidity risk, and limits the firm's ability to invest in growth or execute strategic fixes sustainably.
Negative margins and net loss
Negative EBIT/EBITDA margins and a net loss reflect structural profitability issues, implying core economics aren't covering fixed costs. Without margin recovery, the firm will struggle to rebuild equity, attract long-term capital, or compete effectively, risking further balance-sheet erosion.

Manabi-aid Co.,Ltd. (184A) vs. iShares MSCI Japan ETF (EWJ)

Manabi-aid Co.,Ltd. Business Overview & Revenue Model

Company DescriptionManabi-aid Co., Ltd. (184A) is a forward-thinking company focused on providing innovative educational solutions and technology-driven services. Operating primarily in the education sector, the company specializes in developing digital learning platforms, educational software, and resources aimed at enhancing learning outcomes for students and educators alike. By leveraging cutting-edge technology and educational research, Manabi-aid aims to bridge gaps in traditional education systems and promote accessible, effective learning experiences.

Manabi-aid Co.,Ltd. Financial Statement Overview

Summary
Overall financials are weak: revenue fell sharply (-53.89%), profitability turned negative with deteriorating EBIT/EBITDA margins, and both operating and free cash flow are negative. The balance sheet shows only moderate stability (debt-to-equity 0.28), but negative ROE and weakening equity reduce confidence.
Income Statement
30
Negative
The income statement shows significant challenges with a dramatic decline in revenue and profitability. The company experienced a negative revenue growth rate of -53.89% in the latest year, and net income turned negative, resulting in a net loss. Margins have deteriorated, with negative EBIT and EBITDA margins, indicating operational inefficiencies and financial distress.
Balance Sheet
55
Neutral
The balance sheet reflects moderate stability with a manageable debt-to-equity ratio of 0.28. However, the return on equity has turned negative due to the net loss, indicating poor returns for shareholders. The equity ratio is relatively stable, suggesting a balanced asset structure, but the overall financial health is weakened by declining equity.
Cash Flow
25
Negative
Cash flow analysis reveals severe issues, with negative operating and free cash flows, indicating liquidity problems. The free cash flow growth rate is negative, and the ratios of operating and free cash flow to net income are unfavorable, highlighting cash generation challenges and potential sustainability risks.
BreakdownApr 2025Apr 2025Apr 2023Apr 2022
Income Statement
Total Revenue289.91M628.72M501.33M290.46M
Gross Profit88.73M423.36M377.68M194.56M
EBITDA-285.44M153.17M118.23M-40.98M
Net Income-318.04M118.40M93.27M-60.20M
Balance Sheet
Total Assets219.67M454.24M369.74M192.66M
Cash, Cash Equivalents and Short-Term Investments29.96M141.61M123.38M50.16M
Total Debt37.84M62.34M97.23M44.22M
Total Liabilities84.25M164.78M198.68M114.87M
Stockholders Equity135.42M289.46M171.06M77.79M
Cash Flow
Free Cash Flow-231.35M59.02M20.19M-59.56M
Operating Cash Flow-218.39M63.81M24.11M-56.93M
Investing Cash Flow-21.97M-7.18M-3.90M-2.55M
Financing Cash Flow128.71M-38.40M53.01M-13.16M

Manabi-aid Co.,Ltd. Technical Analysis

Technical Analysis Sentiment
Negative
Last Price557.00
Price Trends
50DMA
399.56
Negative
100DMA
447.55
Negative
200DMA
532.33
Negative
Market Momentum
MACD
-3.91
Negative
RSI
43.22
Neutral
STOCH
45.50
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:184A, the sentiment is Negative. The current price of 557 is above the 20-day moving average (MA) of 383.75, above the 50-day MA of 399.56, and above the 200-day MA of 532.33, indicating a bearish trend. The MACD of -3.91 indicates Negative momentum. The RSI at 43.22 is Neutral, neither overbought nor oversold. The STOCH value of 45.50 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:184A.

Manabi-aid Co.,Ltd. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (51)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
74
Outperform
¥8.89B9.462.06%29.06%41.54%
63
Neutral
¥2.11B12.001.92%4.25%-6.45%
60
Neutral
¥2.86B31.621.33%-7.47%378.86%
55
Neutral
¥2.91B6.041.68%-4.16%
51
Neutral
$7.86B-0.30-43.30%2.27%22.53%-2.21%
51
Neutral
¥2.40B8.75-1.21%-50.91%
41
Neutral
¥1.26B-10.63
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
JP:184A
Manabi-aid Co.,Ltd.
368.00
-33.00
-8.23%
JP:4720
Johnan Academic Preparatory Institute, Inc.
298.00
56.00
23.14%
JP:6096
RareJob,Inc.
307.00
-99.01
-24.39%
JP:9339
COACH A Co., Ltd.
1,210.00
147.88
13.92%
JP:9345
Bizmates,Inc.
650.00
-349.36
-34.96%
JP:9560
PROGRIT, Inc.
698.00
-450.23
-39.21%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Mar 19, 2026